vimarsana.com
Home
Live Updates
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates : vimarsana.com
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates : vimarsana.com
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
– VOWSTTM is the first orally administered microbiome therapeutic FDA-approved for prevention of recurrence of C. difficile infection in adults following antibacterial treatment for recurrent CDI ...
Related Keywords
Canada ,
United States ,
Eric Shaff ,
Aimmune Therapeutics Inc ,
Ulcerative Colitis Uc Research ,
Development Program ,
Nasdaq ,
Health Science ,
Most Influential Companies ,
Nestle ,
Seres Therapeutics Inc ,
Infection Protection Research ,
Company At Oaktree ,
Exchange Commission ,
Drug Administration ,
Seres Therapeutics ,
Chief Executive Officer ,
Initial Commercial Uptake ,
Pharmacy Benefit Managers ,
Breakthrough Therapy ,
Orphan Drug Designations ,
New England Journal ,
Protection Research ,
Infection Protection ,
Oaktree Capital Management ,
Aimmune Therapeutics ,
Full Prescribing Information ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Allogeneic Hematopoietic Cell ,
Markets ,